3451 - 3475 of 5832 Results
Title
Year
- EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease2020OPENTitle: EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 543End Page: 558Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191841Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191841?id=journal-of-parkinsons-disease%2Fjpd191841Citation Count: 23
- mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease2020OPENTitle: mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s diseaseJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-019-0214-xBest OA location URL: https://www.nature.com/articles/s41746-019-0214-x.pdfCitation Count: 95
-
OPENTitle: Network Analysis for Complex Neurodegenerative DiseasesJournal Name: Current Genetic Medicine ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 17End Page: 25Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40142-020-00181-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40142-020-00181-z.pdfCitation Count: 16
- Utilization Behavior Associated with Communicating Hydrocephalus with Resolution Post–Ventriculoperitoneal Shunting2020OPENTitle: Utilization Behavior Associated with Communicating Hydrocephalus with Resolution Post–Ventriculoperitoneal ShuntingJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 338End Page: 339Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12898Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12898Citation Count: 0
-
OPENTitle: Falls Risk in Relation to Activity Exposure in High-Risk Older AdultsJournal Name: The Journals of Gerontology: Series APublisher: Oxford University Press (OUP)Vol: 75Issue #: 6Start Page: 1198End Page: 1205Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/gerona/glaa007Best OA location URL: https://academic.oup.com/biomedgerontology/article-pdf/75/6/1198/33283332/glaa007.pdfCitation Count: 55
-
OPENTitle: Comparison of an Online-Only Parkinson’s Disease Research Cohort to Cohorts Assessed In PersonJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 677End Page: 691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191808Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191808?id=journal-of-parkinsons-disease%2Fjpd191808Citation Count: 24
- Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing Nanoliposomes2020OPENTitle: Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing NanoliposomesJournal Name: Journal of the American Heart AssociationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1161/jaha.119.014810Best OA location URL: https://doi.org/10.1161/jaha.119.014810Citation Count: 22
-
OPENTitle: Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in AdultsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 4Start Page: 461End Page: 461Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4565Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2758316/jamaneurology_isaacson_2020_oi_190108.pdfCitation Count: 53
- A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein research2020OPENTitle: A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein researchJournal Name: Journal of NeurochemistryPublisher: WileyVol: 153Issue #: 1Start Page: 103End Page: 119Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/jnc.14955Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14955Citation Count: 55
-
OPENTitle: Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case reportJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 36End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.013Best OA location URL: https://europepmc.org/articles/pmc7085430?pdf=renderCitation Count: 11
-
OPENTitle: Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 15End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.005Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/220676/220676.pdfCitation Count: 1
-
OPENTitle: Analysis of common and rare VPS13C variants in late-onset Parkinson diseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000385Best OA location URL: https://ng.neurology.org/content/nng/6/1/385.full.pdfCitation Count: 19
- Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime Sleepiness2020OPENTitle: Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime SleepinessJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.01353Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.01353/pdfCitation Count: 14
- Perspectives on Deep Brain Stimulation and Its Earlier Use for Parkinson’s Disease: A Qualitative Study of US Patients2020OPENTitle: Perspectives on Deep Brain Stimulation and Its Earlier Use for Parkinson’s Disease: A Qualitative Study of US PatientsJournal Name: Brain SciencesPublisher: MDPI AGVol: 10Issue #: 1Start Page: 34End Page: 34Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci10010034Best OA location URL: https://www.mdpi.com/2076-3425/10/1/34/pdf?version=1578474005Citation Count: 13
-
OPENTitle: Diagnostic experience reported by caregivers of patients with frontotemporal degenerationJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 4Start Page: 298End Page: 306Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000738Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508333Citation Count: 18
-
OPENTitle: Disease severity and quality of life in homebound people with advanced Parkinson diseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 4Start Page: 277End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000716Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508339Citation Count: 26
-
OPENTitle: Neurodegeneration in Narcolepsy‐Associated Rapid Eye Movement Sleep Behavior DisorderJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 208End Page: 210Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12895Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12895Citation Count: 3
-
OPENTitle: Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson diseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page: 40End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000702Best OA location URL: https://europepmc.org/articles/pmc7057070?pdf=renderCitation Count: 21
- Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands2020OPENTitle: Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased LigandsJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 11Issue #: 3Start Page: 385End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.9b00575Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074212Citation Count: 9
-
OPENTitle: Symptom burden among individuals with Parkinson diseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page: 65End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000746Best OA location URL: https://europepmc.org/articles/pmc7057075?pdf=renderCitation Count: 36
-
OPENTitle: The New Freezing of Gait Questionnaire: Unsuitable as an Outcome in Clinical Trials?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 199End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12893Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12893Citation Count: 77
-
OPENTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participantsJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000680Best OA location URL: https://europepmc.org/articles/pmc7057071?pdf=renderCitation Count: 21
- NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy2020OPENTitle: NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 3Start Page: 1762End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1909110117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1762.full.pdfCitation Count: 103
- Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA2020OPENTitle: Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNAJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 3Start Page: 1457End Page: 1467Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1905057117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1457.full.pdfCitation Count: 88
- Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease2020OPENTitle: Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0574-0Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-019-0574-0Citation Count: 30